Most founders who struggle to raise don't have a product problem. They have a commercial clarity problem — and they usually don't know it until they're already in the room.
we've been in enough early investor conversations, on both sides, to know where founders lose rooms. It's almost never the product. The product is usually fine — often genuinely good. What falls apart is the commercial logic underneath it: who exactly is buying this and why, what the unit economics look like at scale, and how the business gets from here to a size that justifies the capital being asked for.
Analysis by CB Insights of startup failures consistently identifies running out of cash and the absence of real market need as the two leading causes of early-stage business failure — both of which are fundamentally commercial questions, not product ones. Getting to a credible answer to those questions before you're in front of investors isn't just useful preparation. It's the difference between a conversation that builds momentum and one that politely ends at pitch deck slide seven.
This piece isn't about how to pitch. It's about the thinking that has to happen first.
Every investor question is asking one of three things — learn to hear which one
Investor questions in early-stage meetings can feel like they're covering enormous ground. Unit economics. NPS. Churn. Sales cycle length. Team backgrounds. Competitive landscape. It can feel like a comprehensive exam on every aspect of the business.
It isn't. Underneath the surface variation, almost every investor question is probing one of three things: is the market real and large enough? Can this team win in it? And is there a credible path to a business that earns more than it costs to run?
When an investor asks about churn, they're asking whether the market is real in a durable way — not just as a one-time curiosity. When they ask about sales cycle length, they're asking about capital efficiency: a product that takes eighteen months to sell has very different capital requirements to one that converts in a week, and that changes the fundraising conversation fundamentally. When they ask about the team's domain experience, they're assessing whether this group of people can execute on what they're describing — or whether someone better-resourced could get there faster.
Understanding the question behind the question lets founders give answers that are genuinely useful — not technically accurate but completely beside the point.
The founders who handle these conversations best are the ones who've done this translation work themselves before sitting down with investors. They know which of the three underlying questions each part of their business speaks to, and they've prepared honest answers to all three.
TAM isn't an opportunity — it's a commitment you're making about who you're selling to
Total addressable market figures are among the most frequently misused elements of an early investor presentation. The temptation to cite a large number — typically sourced from a market research report with a generous definition of the category — is understandable. Founders want to signal scale of opportunity.
Experienced investors aren't impressed by large TAM numbers. They're impressed by founders who can explain, from the ground up, exactly which customers they're targeting, why those customers have an acute and persistent problem today, and how many of them there realistically are. That exercise almost always produces a smaller number than a top-down TAM. It also produces something far more credible: a specific customer archetype, a specific problem, and a realistic sense of the business you can build by solving it.
The framing that works in these conversations isn't "the total market is £4 billion." It's "there are approximately 8,000 businesses in the UK that fit our customer profile exactly, our current conversion rate suggests we can reach 400 of them in the next two years, and at our target ACV that's a £12m ARR business by year three." That's a commitment about who you're selling to, what it takes to sell to them, and what that builds to. It's investable. A £4bn TAM with no further specificity is not.
Pricing is where commercial confidence is most visible — and most often absent
Founders consistently underweight their pricing decisions. Price is treated as a number to arrive at through competitive benchmarking rather than as a strategic signal that reveals how well you understand your customer.
The pricing conversation in an investor meeting is one of the most revealing exchanges in the whole process — not because the specific number matters enormously at early stage, but because the reasoning behind it tells an investor everything about the depth of the founder's market understanding.
A founder who has stress-tested their pricing through real conversations with real customers — who knows what alternatives those customers currently use and what they pay, who understands why their pricing model reflects the way value is actually delivered rather than just what the market will tolerate — is operating in a completely different space to one who benchmarked three competitors and landed in the middle.
Pricing confidence is commercial confidence. It signals that the founder has done the work — and experienced investors can tell immediately when they have and when they haven't.
The practical question to ask before any investor conversation: can we explain our pricing from first principles, starting with the customer problem and the value we deliver, without once mentioning what competitors charge? If the answer is no, the pricing conversation isn't ready.
Route to scale is the gap most founders leave — and the one investors probe hardest
Of the three core commercial questions, route to scale is the one founders most consistently underestimate. The early customer acquisition story is usually coherent — personal networks, founder-led sales, early adopter communities, warm introductions. The challenge investors are really probing is what happens when those channels run out.
Scaling past the first 20–30 customers almost always requires a different motion. Different channels, different cost structures, different kinds of salespeople, different conversion timelines. The transition from founder-led selling to repeatable commercial process is where most early-stage businesses stall — and investors with deal experience know it, because they've watched it happen in their portfolios.
A credible route to scale answer requires specificity on three things: which channels, at what unit economics, and at what point in the growth curve. "We'll use content marketing and partnerships" is not a route to scale. "We're seeing £340 CAC through LinkedIn with a 14-week sales cycle, and our current pipeline suggests that scales to £3.2m ARR before we hit diminishing returns on that channel, at which point we'll be adding an outbound team" — that's an answer.
The founders who handle this best treat it as a working hypothesis rather than a fixed prediction. They have a plan, they can explain the logic, and they're honest about where the assumptions are. That combination — directness about what they know and intellectual honesty about what they don't — is far more credible than false certainty, and experienced investors respond to it accordingly.
Getting to commercial clarity before you need it
The founders who consistently have the best investor conversations are the ones who've done the commercial thinking before they needed to. Not because they had better businesses, but because they'd taken the time to pressure-test their own logic — on pricing, on customer segmentation, on unit economics, on route to scale — before sitting down with people whose job is to find the holes.
That preparation takes work. It requires real customer conversations, not just market research reports. It requires financial modelling that starts from realistic assumptions rather than the revenue targets the business needs to justify the valuation. And it requires a founder who's willing to sit with uncomfortable answers long enough to figure out what to do about them.
At Eranos, we work with early-stage founders to build exactly that kind of commercial foundation — the clarity that makes a genuinely strong idea investable, and a strong investor conversation something a founder actually looks forward to. If you're preparing for a raise and want to stress-test your commercial thinking before you're in the room, get in touch.
Published by Eranos ·